You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Refer a Patient for Outpatient COVID-19 Therapy

Baystate Health provides both intravenous antiviral and monoclonal antibody treatments for COVID-19.

At this time, the recommended treatment for mild to moderate COVID-19 is oral therapy/Paxlovid, which can be readily prescribed. Almost 80% of those eligible for treatment can be prescribed Paxlovid by their primary care provider and do not need a referral. Find out if you are eligible for Paxlovid.

If your patient is not eligible for Paxlovid, they may be treated with infusion. All treatments requiring infusion are done at Baystate Noble Hospital ICTU.

How to Refer a Patient for COVID-19 Treatment at Baystate Health

If you believe your patient is eligible for infusion therapy and the patient agrees to be considered for COVID-19 outpatient treatment, please follow the steps below to make a referral. If you are a patient interested in this treatment, please talk to your healthcare provider.

Refer a Patient

If you are a Baystate Health network provider, you can send a CIS message to the “COVID Outpatient Therapy” pool with the necessary patient information including the date of symptom onset, date of positive test, COVID vaccination status, and comorbidities that confer high risk for severe COVID illness.

Health insurance is not a requirement to be treated. For questions, call 413-795-0566.

COVID-19 Infusion Treatments

Remdesivir (Antiviral Treatment)

This treatment is given via infusion daily for three consecutive days. This should be started as soon as possible after COVID-19 diagnosis within seven days of onset of symptoms.

Remdesivir is currently approved by the FDA for use in hospitalized individuals, and authorized for non-hospitalized patients with risk factors for severe illness.